X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (73) 73
female (52) 52
male (50) 50
adult (45) 45
middle aged (36) 36
oncology (33) 33
aged (25) 25
hematology (25) 25
animals (22) 22
research (17) 17
cancer (16) 16
young adult (15) 15
leukemia (14) 14
treatment outcome (14) 14
abridged index medicus (13) 13
adolescent (13) 13
aged, 80 and over (13) 13
children (13) 13
biochemistry & molecular biology (12) 12
risk factors (12) 12
care and treatment (11) 11
immunology (11) 11
mice (11) 11
mexico (10) 10
retrospective studies (10) 10
cell biology (9) 9
cells (9) 9
chemotherapy (9) 9
child (9) 9
diabetes (9) 9
hematology, oncology and palliative medicine (9) 9
kaplan-meier estimate (9) 9
patients (9) 9
proteins (9) 9
therapy (9) 9
management (8) 8
mortality (8) 8
outcomes (8) 8
prognosis (8) 8
rats (8) 8
research article (8) 8
risk (8) 8
surgery (8) 8
usage (8) 8
acute myeloid leukemia (7) 7
case-control studies (7) 7
cell line, tumor (7) 7
cell proliferation (7) 7
cohort studies (7) 7
health aspects (7) 7
leukemia, myeloid, acute - drug therapy (7) 7
metabolism (7) 7
obesity (7) 7
physiological aspects (7) 7
recurrence (7) 7
remission (7) 7
acute myelogenous leukemia (6) 6
antineoplastic agents - therapeutic use (6) 6
antineoplastic combined chemotherapy protocols - therapeutic use (6) 6
expression (6) 6
gene expression (6) 6
identification (6) 6
protein kinase inhibitors - therapeutic use (6) 6
rats, wistar (6) 6
remission induction (6) 6
studies (6) 6
survival (6) 6
transplantation (6) 6
activation (5) 5
acute lymphoblastic-leukemia (5) 5
acute myeloid-leukemia (5) 5
adults (5) 5
age (5) 5
antineoplastic agents - adverse effects (5) 5
apoptosis (5) 5
bone-marrow-transplantation (5) 5
chronic myeloid leukemia (5) 5
dasatinib (5) 5
disease (5) 5
drug administration schedule (5) 5
drug therapy (5) 5
emergency medicine (5) 5
endocrinology & metabolism (5) 5
follow-up (5) 5
gene frequency (5) 5
imatinib (5) 5
inflammation (5) 5
insulin (5) 5
kinase (5) 5
medicine, general & internal (5) 5
mitochondria (5) 5
myeloid leukemia (5) 5
neoplasms - pathology (5) 5
neurosciences (5) 5
patient outcomes (5) 5
phosphorylation (5) 5
review (5) 5
tyrosine kinase inhibitor (5) 5
alleles (4) 4
alzheimer's disease (4) 4
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 2018, Volume 378, Issue 25, pp. 2386 - 2398
Among patients with IDH1 -mutated relapsed or refractory leukemia, daily oral ivosidenib, an IDH1 inhibitor, induced molecular clearance of leukemic cells from... 
MEDICINE, GENERAL & INTERNAL | IDH2 MUTATIONS | METAANALYSIS | ACUTE MYELOID-LEUKEMIA | PROGNOSTIC-SIGNIFICANCE | DIFFERENTIATION | INHIBITOR | Glycine - analogs & derivatives | Recurrence | Follow-Up Studies | Glycine - adverse effects | Cell Count | Humans | Middle Aged | Pyridines - pharmacokinetics | Drug Resistance, Neoplasm | Male | Isocitrate Dehydrogenase - antagonists & inhibitors | Dose-Response Relationship, Drug | Enzyme Inhibitors - administration & dosage | Young Adult | Pyridines - adverse effects | Enzyme Inhibitors - pharmacokinetics | Aged, 80 and over | Leukemia, Myeloid, Acute - drug therapy | Adult | Female | Glycine - administration & dosage | Enzyme Inhibitors - adverse effects | Glycine - pharmacokinetics | Pyridines - administration & dosage | Administration, Oral | Isocitrate Dehydrogenase - genetics | Survival Rate | Remission Induction | Leukemia, Myeloid, Acute - mortality | Adolescent | Aged | Mutation | Hemoglobins - analysis | Leukemia, Myeloid, Acute - genetics | Usage | Myelocytic leukemia | Gene mutations | Physiological aspects | Genetic aspects | Nonlymphoid leukemia | Research | Drug therapy | Isocitrate dehydrogenase | Risk factors | Thrombocytopenia | Myeloid leukemia | Leukemia | FDA approval | Cancer therapies | Patients | Investigations | Leukocytosis | Collaboration | Point mutation | Remission | Acute myeloid leukemia | Drug dosages | Neutropenia | Tumors
Journal Article
Cancer cell, ISSN 1535-6108, 2012, Volume 22, Issue 5, pp. 585 - 600
Journal Article
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 11, pp. 1096 - 1104
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2017, Volume 377, Issue 8, pp. 723 - 732
Journal Article
Applied surface science, ISSN 0169-4332, 06/2019, Volume 479, pp. 25 - 30
Dual Function Materials (DFM) are composed of an alkali or alkaline earth CO2 adsorbent phase and a supported catalyst. It selectively captures CO2 which is... 
In-situ DRIFTS | Dual Function Materials | Catalytic CO2 conversion to CH4 | CO2 capture | Alkaline adsorbents | PHYSICS, CONDENSED MATTER | PHYSICS, APPLIED | HYDROGENATION | CONVERSION | SYNTHETIC NATURAL-GAS | CHEMISTRY, PHYSICAL | ADSORPTION | LOW-TEMPERATURE | POWER-TO-GAS | RENEWABLE ENERGY | SURFACE | FLUE-GAS | CARBON-DIOXIDE | MATERIALS SCIENCE, COATINGS & FILMS
Journal Article
Journal Article
BMC medical genetics, ISSN 1471-2350, 2017, Volume 18, Issue 1, pp. 46 - 6
Journal Article
Hematology reports, ISSN 2038-8322, 11/2019, Volume 11, Issue 4, p. 8395
.... Jillella,1 Martha L. Arellano,1 Leonard T. Heffner,1 Manila Gaddh,1 Amelia A. Langston,1 Hanna J. Khoury,1 Abhishek Mangaonkar,2 Vamsi K. Kota1 1Department... 
Promyeloid leukemia | Acute promyeloid leukemia
Journal Article
2009, 4th ed., A Bradford book, ISBN 026201341X, xvii, 1294 p., [56] p. of plates
Book
The lancet oncology, ISSN 1470-2045, 2018, Volume 19, Issue 2, pp. 216 - 228
Elderly patients (aged ≥65 years) with acute myeloid leukaemia have poor outcomes and no effective standard-of-care therapy exists. Treatment with... 
INTENSIVE CHEMOTHERAPY | BCL-2 INHIBITION | OLDER PATIENTS | ONCOLOGY | ABT-199 | CARE | Antimitotic agents | Aged patients | Antineoplastic agents | Analysis
Journal Article
Journal Article